Tobacco Use: A Global Public Health Problem

Aug.25.2023
Tobacco use remains a global public health issue, particularly affecting young people, says Coordinator of Pulmonology Course.

Tobacco Use Still a Public Health Problem, Says Coordinator of Pulmonology Course

 

According to Dr. Margarita Isabel Cervantes Rodríguez, coordinator of the undergraduate pulmonology course affiliated with the internal medicine module, smoking continues to be a global public health problem, unfortunately affecting young people from an early age with exposure to both tobacco and electronic cigarettes.

 

The pulmonologist explained that, for example, in vaping, unlike cigarette burning, there is no combustion of fuel. However, the quantities of nicotine in electronic cigarettes are higher, as well as the accessibility of these products. They can be easily obtained from kiosks outside certain shopping centers, as well as other stores and gas stations.

 

"In this way, young people are exposed to a highly addictive substance that leads to the consumption of other toxic substances in combination or eventually," such as marijuana, cocaine, and other drugs," she said.

 

She mentioned that there are currently various campaigns to quit tobacco use, which has led to the emergence of electronic cigarettes. "We know that we have more than four thousand known toxic substances, with over 50 of them being carcinogens, and nicotine is the main addictive substance," she added.

 

She reiterated that campaigns have been carried out over the years to quit smoking, such as banning cigarette advertising on television and prohibiting posters that promote smoking. Despite the increase in efforts, consumption continues.

 

Cervantes Rodríguez stated that cigarette packages now display images depicting the consequences of smoking, such as abortion, birth defects, animal extinction, and pollution of the seas and oceans.

 

"To date, we have a cessation plan in place that consists of a treatment that helps the body release dopamine, along with nicotine replacement therapy such as patches. For patients with serious dependencies, we offer a second nicotine replacement with gums or lozenges," she explained.

 

She added that this is not enough; there should also be cognitive-behavioral and psychological support to help people quit smoking because tobacco use is a disease.

 

She emphasized that with these cessation plans, improvements in tobacco abstinence, especially nicotine, have been observed in an eight to 12-week treatment plan, which leads to a high success rate in quitting smoking.

 

Regarding the negative effects of tobacco use, she mentioned dependency, consumption of other substances, and, in some cases, the development of Chronic Obstructive Pulmonary Disease (COPD) and lung cancer, which are among the leading causes of death worldwide. Other effects include diseases in children, environmental pollution, and more.

 

"There is treatment nowadays to quit smoking, and we must not forget that it is not only the person who smokes that is harmed, but also the effects of second and third-hand smoke on those around them," she concluded.

 

We will continue to keep you informed.

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Product | OXBAR Lists GOSLIM Disposable Vape on Its Website, Featuring Embedded Leather and a Slim Display Window Design
Product | OXBAR Lists GOSLIM Disposable Vape on Its Website, Featuring Embedded Leather and a Slim Display Window Design
OXBAR has updated its official website and listed a new disposable product, GOSLIM. The device is rated at 26,000 puffs, measures 40 × 22 × 110 mm, and weighs about 75 g, featuring an “embedded leather” exterior design. It supports two power modes—ECO and BOOST—and includes a digital display showing remaining battery percentage, remaining e-liquid level, and the active mode.
Jan.21 by 2FIRSTS.ai
2Firsts Interview | Bengt Wiberg: Why the Oral Health Risks of Nicotine Pouches Merit Further Study
2Firsts Interview | Bengt Wiberg: Why the Oral Health Risks of Nicotine Pouches Merit Further Study
As nicotine pouches gain global traction as a lower-risk alternative to smoking, questions are emerging about their potential oral health effects. In a 2Firsts interview, Stingfree AB founder Bengt Wiberg discusses why gum irritation and oral lesions warrant closer scrutiny within the broader framework of tobacco harm reduction.
Jan.06
BREAKING: China Brings Nicotine Pouches Under Tobacco Monopoly Regulation, Signaling Major Shift for Oral Products
BREAKING: China Brings Nicotine Pouches Under Tobacco Monopoly Regulation, Signaling Major Shift for Oral Products
China has for the first time issued clear regulatory rules for nicotine pouches and other oral nicotine products, formally classifying them under the tobacco monopoly alongside cigarettes and tobacco, ending a long-standing legal grey zone and laying the regulatory groundwork for their potential domestic launch.
Jan.09 by Alan Zhao | 2Firsts Perspectives
U.S. FDA Posts Final ZYN MRTP Materials, Sets March 4 Deadline for Public Comments
U.S. FDA Posts Final ZYN MRTP Materials, Sets March 4 Deadline for Public Comments
U.S. FDA has released the final batch of materials for ZYN MRTP applications and set March 4 (11:59 p.m. ET) as the deadline for public comments to be considered in the agency’s review.
Feb.03 by 2FIRSTS.ai
Ispire Q2 FY2026 revenue falls to $20.3M as it trims lower-quality customers; A/R down nearly 20%
Ispire Q2 FY2026 revenue falls to $20.3M as it trims lower-quality customers; A/R down nearly 20%
Ispire reported a sharp year-on-year revenue decline in Q2 FY2026 as it shifted away from lower-quality customers, while cutting operating expenses and narrowing its net loss. The company also highlighted improved collections, with net accounts receivable down nearly one-fifth since June 30, 2025, alongside ongoing manufacturing and technology initiatives.
Feb.09 by 2FIRSTS.ai
China to Cancel VAT Export Rebates on E-Cigarette Products from April 1, 2026
China to Cancel VAT Export Rebates on E-Cigarette Products from April 1, 2026
China’s Ministry of Finance and State Taxation Administration have announced adjustments to export tax rebate policies, placing nicotine-containing non-combustible inhalation products within the scope of items subject to rebate cancellation. The measures will take effect from April 1, 2026.
Regulations
Jan.10